Silence Therapeutics (SLN)
NASDAQ:SLN
Holding SLN?
Track your performance easily

Silence Therapeutics (SLN) Balance Sheet

107 Followers

Silence Therapeutics Balance Sheet

Silence Therapeutics's total assets for Q4 2022 were £107.50M, a decrease of -13.33% from the previous quarter. SLN total liabilities were £85.43M for the fiscal quarter, a -4.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
£ 93.82M£ 107.50M£ 96.19M£ 85.97M£ 46.08M
Total Liabilities
£ 76.77M£ 85.43M£ 87.67M£ 76.91M£ 25.17M
Total Equity Gross Minority
£ 17.05M£ 22.07M£ 8.53M£ 9.06M£ 20.91M
Total Capitalization
£ 75.96M£ 85.56M£ 8.53M£ 9.06M£ 20.91M
Preferred Stock Equity
-----
Capital Lease Obligations
---£ 341.00K£ 287.00K
Currency in GBP

Silence Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis